ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed

Baoping Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4855-7065; OpenAlex author ID A5051409818. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer. Last author DOI 10.1515/biol-2022-0630 ↗
Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-canc… Co-author DOI 10.1186/s12935-022-02622-x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kunqiao Hong · 1 shared paper, 2023 · strength 0.24
- Paper SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer. DOI 10.1515/biol-2022-0630 ↗
Shiyun Tan · 1 shared paper, 2022 · strength 0.22
- Paper Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach … DOI 10.1186/s12935-022-02622-x ↗
Xingchen Liao · 1 shared paper, 2022 · strength 0.22
- Paper Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach … DOI 10.1186/s12935-022-02622-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.